Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

Quality research relies on more than using the correct methods and controlling the variables. The quality of the material being studied is important too. In preclinical research, the purity, identity, storage, and stability of the peptides, along with accurate documentation, can affect how confidently researchers can interpret their findings. That’s why the quality of the […]

The post Why Peptide Quality Matters in Preclinical Research appeared first on Medical News Bulletin.

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

The assessment of hearing aids for decades has been based mainly on their functional aspects. They were little, white and to be forgotten. The primary objective was to make the sound louder, rather than appearance having much to do with the conversation. This is slowly changing. Many manufacturers now make design a part of the […]

The post The reasons why Design Awards are starting to matter in hearing aids appeared first on Medical News Bulletin.

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

Your teeth endure a lot of wear throughout the day, from sipping coffee to enjoying your favorite meals. While tooth enamel is very strong, some everyday habits can gradually wear it away. Unfortunately, once enamel is lost, your body cannot naturally grow it back. Enamel erosion can cause tooth sensitivity, discoloration, and a higher risk […]

The post What Causes Enamel Erosion and How Can You Prevent It? appeared first on Medical News Bulletin.

Children wearing Essilor Stellest 2.0 lenses for 6 months had reductions in myopia progression comparable to changes in children who wore the original version of the glasses for a year, according to a press release from EssilorLuxottica.
“The treatment response appears to be effectively twice as fast,” Yang Xiao, principal investigator and professor at Zhongshan Ophthalmic Center at Sun Yat-sen University in China, said in the release. “These findings add important clinical evidence from China to the global body of research on HALT Max technology.”
Essilor Stellest 2.0 glasses with highly

Results showed a standardized international registry may capture longitudinal patterns after scapholunate ligament surgery, with early worsening function and pain postoperatively before improvement and stabilization.
“The expected postoperative trajectory following scapholunate ligament repair and reconstruction is something that will help build and set patient expectations but also help surgeons determine when patients are not following the expected postoperative recovery trajectory — and if it is a meaningful setback, if they should intervene, if they should be monitoring their

Alcon has acquired Neurotech Pharmaceuticals and Encelto, its macular telangiectasia type 2 therapy, according to a press release.
Alcon paid $550 million in the acquisition of Neurotech and could make contingent payments based on commercial milestones, according to the release.
Encelto (revakinagene taroretcel-lwey) is an encapsulated cell therapy that received FDA approval for the treatment of macular telangiectasia (MacTel) type 2 in March 2025. It is the only FDA-approved treatment for MacTel type 2.
Jim Mazzo, executive chairman at Neurotech, told Healio he was pleased with the acquisition.

Exercise may reduce the burden of perimenopause symptoms, especially for mental health, according to research presented at The Menopause Society’s annual meeting.
Liudmila Zhaunova, PhD, the director of science at Flo Health, a global women’s health app, and colleagues conducted a cross-sectional study to evaluate connections between perimenopause symptom burden and physical activity frequency. They included international data from Flo, a menstrual tracking application.
The researchers included 1,808 users of the app from 87 countries, all aged at least 35 years who self-reported being in

E-scooter trauma admissions are on the rise, and severe injury from e-scooters is more likely to occur in patients under the age of 16 years, according to a pair of new studies.
There are more e-scooter riders on the roads than ever before as usage has soared in recent years, according to researchers. More riders have meant more stress on hospital trauma centers. But until late 2020, e-scooter injuries did not have a specific ICD-10-CM code, which has led to insufficient data on the true burden e-scooter injuries have had on these trauma centers.
A new study from researchers at Howard

NASHVILLE, Tenn. — Antidrug antibodies did not appear to negatively affect outcomes in patients with inflammatory bowel disease after initiation of subcutaneous infliximab following a “drug holiday,” according to a presenter.
Results of a post-hoc analysis presented at ACG Annual Scientific Meeting also showed serum infliximab (Zymfentra, Celltrion) concentrations increased over time after subcutaneous initiation, regardless of antidrug antibody (ADA) status.
Patients with IBD may need to halt treatment — also called a “drug holiday” — for a number of reasons. While the impact of reintroducing

The FDA approved bepirovirsen as the first antisense oligonucleotide for chronic hepatitis B virus infection, alongside existing antiviral therapy for eligible adults without cirrhosis.
Bepirovirsen (Hibsago, GSK) is indicated for adults who have taken HBV antiviral therapy for at least 6 months, have suppressed levels of HBV and have hepatitis B surface antigen levels of 3,000 IU/mL or less.
The FDA based its decision on data from phase 3 B-Well 1 and B-Well 2 trials, which showed that 6 months of bepirovirsen treatment achieved functional cure in 19% of patients, compared with none who